The President of the United States, Donald Trump, announced this Thursday (6) that pharmaceutical companies Eli Lilly and Novo Nordisk agreed to reduce significantly the prices of your medications for weight loss, like Wegovy and Zepbound.
According to him, the companies committed to offering the
“This will reduce the cost of Wegovy from $1,350 per month to ultimately $250, and Zepbound from $1,080 to $346,” Trump said. He added that Eli Lilly and Novo Nordisk are committing to offering the oral GLP-1 medications for “a maximum of $149 per month.”
The president also declared that Medicare and Medicaid “will now cover these drugs”, and that reduced-price versions will be “available soon on a government website”, TrumpRX – which should be launched by the end of the year.
Trump also said that “they will arrive soon” on the market and highlighted that “Americans must pay the lowest prices for medicines in the world”.
According to the president, Eli Lilly plans to invest US$27 billion and Novo Nordisk will direct US$10 billion in production in the United States. He did not mention deadlines.
The Republican also stated that “it would be devastating for our country if the Court decides that the tariffs are illegal.”
